NSE · AKUMS
Akums Drugs and Pharmaceuticals Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#530
of 5,072 stocks
▲ 121W
Peak #530 · 27 Sep 2026
A midcap name in Healthcare, Akums Drugs and Pharmaceuticals Limited carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 75%, and is growing revenue modestly.
Market Cap
12,547.72 Cr
P/E Ratio
49.16
P/B Ratio
3.77
ROE
7.70%
ROCE
11.40%
Dividend Yield
0.24%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 1,166.63 Cr | 1,157.87 Cr | 1,159.59 Cr | 1,017.53 Cr |
| Net Profit | 100.98 Cr | 81.34 Cr | 67.67 Cr | 42.70 Cr |
| EPS | 6.53 | 5.53 | 4.33 | 2.66 |
| Operating Profit | 163.99 Cr | 146.90 Cr | 141.54 Cr | 88.98 Cr |
Shareholding pattern
Promoter
75.26%
Public
22.01%
Mutual fund holdings
₹776.99
Cr total
14
Schemes
7
Fund Houses
₹776.99 Cr
Total Exposure
Franklin Templeton Mutual Fund₹477.16 Cr (61.4%)
ICICI Prudential Mutual Fund₹186.16 Cr (24.0%)
Nippon India Mutual Fund₹104.98 Cr (13.5%)
Motilal Oswal Mutual Fund₹7.10 Cr (0.9%)
Samco Mutual Fund₹1.53 Cr (0.2%)
Others₹0.05 Cr (0.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 03 Jul 2026 | Dividend | Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.